China
· Delayed Price · Currency is CNY Jiangsu Nhwa Pharmaceutical Co., LTD Company Description
Jiangsu Nhwa Pharmaceutical Co., LTD engages in production, marketing, and services related to central nervous system drugs in China.
The company offers Duloxetine Hcl, Risperidone, Ziprasidone Hcl, Etomidate Fat Emulsion, Gabapentin, Zaleplon, etc., as well as Iptakalim, an anti-hypertension drug.
It also provides penehyquinac acid hydrochloride injection, sufentanil citrate injection, oxeridine fumarate, injection, alfentanil hydrochloride injection, oxycodone hydrochloride injection, duloxetine hydrochloride enteric dissolving capsules, olanzapine tablets, midazolam hydrochloride oral solution, clonazepam injection, pregabalin capsules, lacosamide, injection, mivacuride injection, etc. The company’s products are used for treatment of anesthesiology, psychiatry and neurology, as well as APIs.
Jiangsu Nhwa Pharmaceutical Co., LTD was founded in 1978 and is headquartered in Xuzhou, China.
| Country | China |
| Founded | 1978 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 5,923 |
| CEO | Jiaquan Sun |
Contact Details
Address: Enhua Technology Building Xuzhou, Jiangsu Province 221009 China | |
| Phone | 86 40 0900 2262 |
| Website | nhwa-group.com |
Stock Details
| Ticker Symbol | 002262 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000CG8 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jiaquan Sun | GM and Non-Independent Director |
| Gangsheng Li | Chief Financial Officer |
| Qing Fu | Deputy GM and Non-Independent Director |
| Zengliang Chen | Deputy GM and Non-Independent Director |
| Ziliang Yang | Deputy GM and Non-Independent Director |
| Bao Zhou Duan CPA | Deputy GM and Secretary |